The most recent study on the CFTR gene complexed with a cationic liposome (GL67A- pGM169: Table 6) in CF epithelial cells established the first proof-of-concept that gene therapy can stabilize the progression of CF lung disease in a Phase IIb trial. This evidence concerns the gene CFTR and cystic fibrosis.